C. Webb Andrews

The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study

Paula D. James, Colleen Notley, Carol Hegadorn et al. · Blood · 2006 · 351 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Ex Vivo Gene Therapy for Hemophilia A That Enhances Safe Delivery and Sustained In Vivo Factor VIII Expression from Lentivirally Engineered Endothelial Progenitors

Hideto Matsui, Masaru Shibata, Brian D. Brown et al. · Stem Cells · 2007 · 105 citations · Full text

Pharmacy, Bioengineering, Hematology +17

Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding

Kyle A. Emmitte, George M. Adjebang, C. Webb Andrews et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells

Hideto Matsui, Masaru Shibata, Brian D. Brown et al. · Blood · 2009 · 57 citations · Full text

Life Sciences, Hematology, Immunology +17

Discovery of thiophene inhibitors of polo-like kinase

Kyle A. Emmitte, C. Webb Andrews, Jennifer G. Badiang et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +13